Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Wheaton Precious Metals Corp — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.91 (market cap $977.37M), while Wheaton Precious Metals Corp trades at $130.35 (market cap $58.87B). The key difference: Wheaton Precious Metals Corp is far larger — about 60.2× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Wheaton Precious Metals Corp pays a 0.6% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Wheaton Precious Metals Corp for 66 Days on average.
| MRVI | WPM | |
|---|---|---|
Market Cap | $977.37M | $58.87B |
Volume | 2,742,564 | 1,966,041 |
Sector | Health | Basic Materials |
52-Week High | $9.00 | $165.72 |
52-Week Low | $2.83 | $94.37 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $1.08B | $60.74B |
Dividend Yield | — | 0.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Wheaton Precious Metals (WPM) trades at $136.03, down 1.51% on the day, amid a bullish technical setup with strong support at $135. The company reported record 2025 results, including $2.31B revenue and $1.47B net income, with earnings consistently beating estimates. Management targets 50% production growth by 2030 without new capital, supported by an expanding deal pipeline.
WPM presents a compelling growth story with high profitability and strong analyst backing, though premium valuations and exposure to volatile precious metal prices pose risks. The consensus price target of $164.80 implies significant upside, driven by operational execution and strategic streaming acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
